Cargando…

TCR-engineered T cell therapy in solid tumors: State of the art and perspectives

T cell engineering has changed the landscape of cancer immunotherapy. Chimeric antigen receptor T cells have demonstrated a remarkable efficacy in the treatment of B cell malignancies in hematology. However, their clinical impact on solid tumors has been modest so far. T cells expressing an engineer...

Descripción completa

Detalles Bibliográficos
Autores principales: Baulu, Estelle, Gardet, Célia, Chuvin, Nicolas, Depil, Stéphane
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Association for the Advancement of Science 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9931212/
https://www.ncbi.nlm.nih.gov/pubmed/36791198
http://dx.doi.org/10.1126/sciadv.adf3700

Ejemplares similares